Novocure Ltd NVCR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
94.22UNCH (UNCH)
Volume
14,214
Close
94.22quote price arrow down-0.87 (-0.91%)
Volume
727,898
52 week range
56.39 - 120.03
Loading...
  • Open93.62
  • Day High95.12
  • Day Low92.20
  • Prev Close95.09
  • 52 Week High120.03
  • 52 Week High Date01/05/23
  • 52 Week Low56.39
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap9.888B
  • Shares Out104.95M
  • 10 Day Average Volume0.89M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change28.45

KEY STATS

  • Open93.62
  • Day High95.12
  • Day Low92.20
  • Prev Close95.09
  • 52 Week High120.03
  • 52 Week High Date01/05/23
  • 52 Week Low56.39
  • 52 Week Low Date06/16/22
  • Market Cap9.888B
  • Shares Out104.95M
  • 10 Day Average Volume0.89M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change28.45

RATIOS/PROFITABILITY

  • EPS (TTM)-0.78
  • P/E (TTM)-120.47
  • Fwd P/E (NTM)-88.80
  • EBITDA (TTM)-59.353M
  • ROE (TTM)-19.03%
  • Revenue (TTM)542.624M
  • Gross Margin (TTM)78.68%
  • Net Margin (TTM)-15.05%
  • Debt To Equity (MRQ)126.78%

EVENTS

  • Earnings Date02/23/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Novocure Ltd

 

Profile

MORE
NovoCure Limited is a global oncology company, which is principally engaged in the development, manufacturing and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua, for the treatment of solid tumor cancers. TTFields are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms. TTFields therapy has applicability across solid tumor types and lines of therapy. It is conducting phase three pivotal...
William Doyle
Executive Chairman of the Board
Asaf Danziger
President, Chief Executive Officer, Director
Wilhelmus Groenhuysen
Chief Operating Officer
Ashley Cordova
Chief Financial Officer
Todd Longsworth
General Counsel
Address
No. 4 The Forum, Grenville Street
Saint Helier
JE2 4UF
Jersey

Top Peers

SYMBOLLASTCHG%CHG
SRPT
Sarepta Therapeutics Inc
119.00-1.25-1.04%
HALO
Halozyme Therapeutics Inc
52.65-0.22-0.42%
NBIX
Neurocrine Biosciences Inc
110.03+2.03+1.88%
ASND
Ascendis Pharma A/S
116.10-1.64-1.39%
KRTX
Karuna Therapeutics Inc
191.99-2.57-1.32%